newsfilter
← Latest News
GlobeNewswire·

uniQure to Announce First Quarter 2026 Financial Results

  • uniQure N.V. will report first quarter 2026 financial results before market open on Tuesday, May 5, 2026.
  • Management will host a conference call at 8:30 a.m. ET on the same day.
  • The webcast will be available via the Events & Presentations section of the uniQure website, with a replay archived for 90 days.
  • Participants can join the Q&A session by dialing (646) 307-1963 or toll-free (800) 715-9871 using conference ID 4607289.
  • Attendees are advised to join the call 15 minutes prior to the start time.
  • The company highlights its hemophilia B gene therapy approval as a milestone & lists an ongoing pipeline for Huntington's disease, refractory temporal lobe epilepsy, Fabry disease, & other severe conditions.
  • Investor contact is Chiara Russo at 781-491-4371 or c.russo@uniQure.com.
  • Media contact is Tom Malone at 339-970-7558 or t.malone@uniQure.com.